Bio-Techne Corporation (TECH)
NASDAQ: TECH · Real-Time Price · USD
53.94
-0.47 (-0.86%)
Jul 11, 2025, 11:05 AM - Market open
Bio-Techne Employees
Bio-Techne had 3,050 employees as of June 30, 2023. The number of employees increased by 50 or 1.67% compared to the previous year.
Employees
3,050
Change (1Y)
50
Growth (1Y)
1.67%
Revenue / Employee
$396,318
Profits / Employee
$43,162
Market Cap
8.46B
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Jun 30, 2023 | 3,050 | 50 | 1.67% |
Jun 30, 2022 | 3,000 | 400 | 15.38% |
Jun 30, 2021 | 2,600 | 300 | 13.04% |
Jun 30, 2020 | 2,300 | 50 | 2.22% |
Jun 30, 2019 | 2,250 | 250 | 12.50% |
Jun 30, 2018 | 2,000 | 200 | 11.11% |
Jun 30, 2017 | 1,800 | 240 | 15.38% |
Jun 30, 2016 | 1,560 | 204 | 15.04% |
Jun 30, 2015 | 1,356 | 335 | 32.81% |
Jun 30, 2014 | 1,021 | 167 | 19.56% |
Jun 30, 2013 | 854 | 7 | 0.83% |
Jun 30, 2012 | 847 | 13 | 1.56% |
Jun 30, 2011 | 834 | 97 | 13.16% |
Jun 30, 2010 | 737 | -9 | -1.21% |
Jun 30, 2009 | 746 | 27 | 3.76% |
Jun 30, 2008 | 719 | 38 | 5.58% |
Jun 30, 2007 | 681 | 44 | 6.91% |
Jun 30, 2006 | 637 | 28 | 4.60% |
Jun 30, 2005 | 609 | 12 | 2.01% |
Jun 30, 2004 | 597 | 11 | 1.88% |
Jun 30, 2003 | 586 | 16 | 2.81% |
Jun 30, 2002 | 570 | 9 | 1.60% |
Jun 30, 2001 | 561 | 64 | 12.88% |
Jun 30, 2000 | 497 | 26 | 5.52% |
Jun 30, 1999 | 471 | 60 | 14.60% |
Jun 30, 1998 | 411 | 46 | 12.60% |
Jun 30, 1997 | 365 | -7 | -1.88% |
Jun 30, 1996 | 372 | 28 | 8.14% |
Jun 30, 1995 | 344 | 67 | 24.19% |
Jun 30, 1994 | 277 | 71 | 34.47% |
Jun 30, 1993 | 206 | - | - |
Sources: Annual number of employees according to filings submitted to the U.S. Securities and Exchange Commission (SEC). Data is also manually gathered from company press releases, IPO filings, and other official sources.
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 94,300 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
TECH News
- 17 days ago - Bio-Techne and USP Announce Collaboration to Accelerate Monoclonal Antibody and Gene Therapy Product Development - PRNewsWire
- 4 weeks ago - ScaleReady Announces a G-Rex® Grant has been awarded to Immuneel Therapeutics - PRNewsWire
- 6 weeks ago - Bio-Techne to Present at Investor Conferences - PRNewsWire
- 2 months ago - ScaleReady awards multiple G-Rex® Grants to leading investigators at the University of Southern California (USC) and the Children's Hospital of Los Angeles (CHLA) - PRNewsWire
- 2 months ago - Bio-Techne to Showcase Next-Generation Solutions for Gene and Cell Therapy at American Society of Gene & Cell Therapy 2025 - PRNewsWire
- 2 months ago - Kytopen and Bio-Techne Collaborate on an Integrated Cellular Engineering Workflow to Expedite Cell Therapy Manufacturing - PRNewsWire
- 2 months ago - Bio-Techne to Present at the BofA Securities 2025 Health Care Conference - PRNewsWire
- 2 months ago - Bio-Techne Corporation (TECH) Q3 2025 Earnings Call Transcript - Seeking Alpha